Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative

July 02, 2026 | The ASCO Post Staff

At a pivotal moment for pancreatic cancer, Break Through Cancer and the Lustgarten Foundation, with support from the Cinelli Family Foundation, has announced a $16 million investment in the Conquering KRAS for Patients with Pancreatic Cancer TeamLab. Spanning six world-class cancer research institutions, this initiative aims to improve outcomes for one of the deadliest cancers by focusing on KRAS, a gene that is mutated in more than 90% of pancreatic cancer cases.

Read More The ASCO Post.

UPDATES AND NEWS

Media Coverage

We can prevent ovarian cancer. Women deserve the option. | USA Today

Media Coverage

Fallopian tube removal may lower ovarian cancer risk | Good Morning America

Press Release

The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-targeted Immunotherapy Strategy for Pancreatic Cancer

Media Coverage

Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives | New York Times

View All

BE PART OF THE MISSION
Stay Informed, Make an Impact

Subscribe

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

* indicates required
Email Format

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.

Media Coverage
6 likes